These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1678526)

  • 1. Opioid mu and delta receptor antagonists reduce wet dog shaking elicited by perforant path stimulation.
    Mitchell CL; Barnes MI; Hudson PM; Hong JS
    Pharmacol Biochem Behav; 1991 Apr; 38(4):801-5. PubMed ID: 1678526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the perforant path alters hippocampal levels of opioid peptides, glutamine and GABA.
    Mitchell CL; Grimes L; Hudson PM; Hong JS
    Brain Res; 1987 Dec; 435(1-2):343-7. PubMed ID: 2892578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus.
    Mazarati A; Liu H; Wasterlain C
    Neuroscience; 1999 Mar; 89(1):167-73. PubMed ID: 10051226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta opioid receptor activation is required to induce LTP of synaptic transmission in the lateral perforant path in vivo.
    Bramham CR; Milgram NW; Srebro B
    Brain Res; 1991 Dec; 567(1):42-50. PubMed ID: 1667745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine lesions of ventral, but not dorsal, dentate granule cells attenuate wet dog shakes elicited by perforant path stimulation.
    Barnes MI; Mitchell CL
    Brain Res; 1990 Mar; 512(1):159-63. PubMed ID: 2337804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glutamate antagonist blocks perforant path stimulation-induced reduction of dynorphin peptide and prodynorphin mRNA levels in rat hippocampus.
    Xie CW; McGinty JF; Lee PH; Mitchell CL; Hong JS
    Brain Res; 1991 Oct; 562(2):243-50. PubMed ID: 1685342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perforant path stimulation differentially alters prodynorphin mRNA and proenkephalin mRNA levels in the entorhinal cortex-hippocampal region.
    Xie CW; Mitchell CL; Hong JS
    Brain Res Mol Brain Res; 1990 Apr; 7(3):199-205. PubMed ID: 1970844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kainic acid as a tool to study the regulation and function of opioid peptides in the hippocampus.
    Hong JS; Grimes L; Kanamatsu T; McGinty JF
    Toxicology; 1987 Oct; 46(2):141-57. PubMed ID: 2890224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids induce convulsions and wet dog shakes in rats: mediation by hippocampal mu, but not delta or kappa opioid receptors.
    Lee PH; Obie J; Hong JS
    J Neurosci; 1989 Feb; 9(2):692-7. PubMed ID: 2537392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region.
    Stevens KE; Shiotsu G; Stein L
    Brain Res; 1991 Apr; 545(1-2):8-16. PubMed ID: 1677606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of endogenous opioid release displaces mu receptor binding in rat hippocampus.
    Wagner JJ; Caudle RM; Neumaier JF; Chavkin C
    Neuroscience; 1990; 37(1):45-53. PubMed ID: 1978741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release.
    Nikolarakis KE; Almeida OF; Yassouridis A; Herz A
    Neuroscience; 1989; 31(1):269-73. PubMed ID: 2570378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal opioid peptides and seizures.
    Hong JS
    Epilepsy Res Suppl; 1992; 7():187-95. PubMed ID: 1361330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term potentiation in direct perforant path projections to the hippocampal CA3 region in vivo.
    Do VH; Martinez CO; Martinez JL; Derrick BE
    J Neurophysiol; 2002 Feb; 87(2):669-78. PubMed ID: 11826036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid actions at mu and delta receptors in the rat dentate gyrus in vitro.
    Piguet P; North RA
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1139-49. PubMed ID: 8394905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid enhancement of perforant path transmission: effect of an enkephalin analog on inhibition and facilitation in the dentate gyrus.
    Wiesner JB; Henriksen SJ; Bloom FE
    Brain Res; 1986 Dec; 399(2):404-8. PubMed ID: 3030491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region.
    Chavkin C; Henriksen SJ; Siggins GR; Bloom FE
    Brain Res; 1985 Apr; 331(2):366-70. PubMed ID: 2859095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.